Pharmacosmos will be closed for the Easter holidays from 14 April to 21 April 2025.

When dextran is used in a pharmaceutical product or medical device, it should always be of pharmaceutical quality.

Technical Quality Dextran is a high purity dextran fraction with selected average molecular weights and molecular weight distributions used as starting or intermediate reagents.

Explore our full range of products

Ultra Narrow

Dextran Ultra is a range of very narrow, dispersed Dextran fractions with polydispersity Mw/Mn below 1.5. This makes our Dextran Ultra highly suitable for characterization, complexing and other pharmaceutical/technical uses where added/increased/additional requirements with regard to narrow distributions and quality are required.

Explore our full range of products

Standards & GPC Standards

Our Standards comes with a complete set of specifications including; weight average molecular weight (Mw), number average molecular weight (Mn), and mean peak molecular weight (Mp)

Explore our full range of products

Derivatives

Pharmacosmos offer Dextran derivatives with the same high standard and requirements to the highest quality as our world-leading Dextran products.

Explore our full range of products

Applications

As a nontoxic and biocompatible polysaccharide, dextran is used widely in research and production in the pharmaceutical, biomedical, and life science industries.

Dextran characteristics

Dextran fractions are characterised by their average molecular weights and molecular weight distributions. Dextran is used in a wide range of industries and fields, including pharma, photography and agriculture.

Beneficial characteristics

The versatile use of dextran products thanks to its favourable properties:

• Neutral and water soluble

• Easily filtered

• Biocompatible

• Biodegradable

• Stable for three or five years

For more information about the various dextran fractions available, please see our overview of Pharmacosmos dextran products.

Get the newest updates on dextrans- Subscribe to our newsletter